Montelukast Sodium
Product Images NDC 50090-5774

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 50090-5774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ecb8c513 E5ee 4501 A240 B2d644615559 01)

Figure 1 (Ecb8c513 E5ee 4501 A240 B2d644615559 01)
A line graph comparing change in height (cm) over 56 weeks on treatment for montelukast sodium 5 mg, beclomethasone 336 mcg, and placebo groups. The x-axis shows weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Three lines represent the three groups with similar growth trends over time.*
FDA Label Image

Structure (Ecb8c513 E5ee 4501 A240 B2d644615559 02)

Structure (Ecb8c513 E5ee 4501 A240 B2d644615559 02)
Chemical structure of montelukast sodium, showing its molecular configuration with characteristic ring and functional groups, including a chlorine atom, sulfur atom, carboxylate group, and aromatic rings, as presented in the image.*
FDA Label Image

Figure 2 (Ecb8c513 E5ee 4501 A240 B2d644615559 03)

Figure 2 (Ecb8c513 E5ee 4501 A240 B2d644615559 03)
A line graph showing mean percent change from baseline over weeks in treatment comparing montelukast sodium and placebo. The x-axis represents weeks in treatment up to 15 weeks, including a washout period from week 12 to 15. The y-axis shows mean percent change. Montelukast sodium shows a higher increasing trend compared to placebo throughout the treatment period.*
FDA Label Image

Image (Ecb8c513 E5ee 4501 A240 B2d644615559 907 2)

FDA Label Image

Label Image (Lbl500905774)

Label Image (Lbl500905774)
montelukast sodium 5 mg chewable tablets packaging label from A-S Medication Solutions. The label indicates each tablet contains 5 mg equivalent to montelukast. The package contains 30 chewable tablets. Storage instructions specify to keep at 68 to 77 degrees Fahrenheit, protected from moisture and light. The label shows dosage instructions to see package insert and includes the product NDC 50090-5774.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.